SUNNYVALE, Calif., Aug. 01, 2017 -- Adesto Technologies Corporation (NASDAQ:IOTS), a leading provider of application-specific, ultra-low power non-volatile memory products, today announced Narbeh Derhacobian, chief executive officer, and Ron Shelton, chief financial officer, will present at the Canaccord Genuity Growth Conference to be held at the InterContinental Hotel in Boston, MA. Management is scheduled to present at 5:00 p.m. on Wednesday, August 9, 2017 and will be available to meet with investors throughout the day.
Portfolio managers and analysts who wish to meet with management should contact their Canaccord Genuity representative to schedule a meeting. A live audio webcast and archived replay of the Company’s presentation will be made available in the Investor Relations section of the Company’s website at www.adestotech.com.
About Adesto Technologies
Adesto Technologies (NASDAQ:IOTS) is a leading provider of application-specific, ultra-low power, smart non-volatile memory products. The company has designed and built a portfolio of innovative products with intelligent features to conserve energy and enhance performance, including Fusion Serial Flash, DataFlash®, EcoXiP™ and products based on its trademark resistive RAM technology called Conductive Bridging RAM (CBRAM®). CBRAM is a breakthrough technology platform that enables 100 times less energy consumption than today's flash memory technologies as well as delivering enhanced performance. For more information, please visit http://www.adestotech.com.
Adesto Technologies and the Adesto logo are trademarks of Adesto Technologies in the United States and other regions. All other trademarks are property of their respective owners.
Company Contact David Viera Director, Corporate Communications 408-419-4844 [email protected] Investor Relations Shelton Group Leanne K. Sievers, President P: 949-224-3874 E: [email protected]


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



